G01N 2333/4756
Neuregulins, i.e. p185erbb2 ligands, glial growth factor, heregulin, aria, neu differentiation factor
Official title: Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
G01N2333/4756 (Neuregulins, i.e. p185erbb2 ligands, glial growth factor, heregulin, aria, neu differentiation factor) appears on 40 US grants and 78 published applications in this corpus.
Search patents in G01N- Granted patents
- 40
- Published applications
- 78
- Assignees
- 49
- Inventors
- 136
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 1 | 2 |
| 2005 | 2 | 5 |
| 2006 | 2 | 4 |
| 2007 | 1 | 5 |
| 2008 | 0 | 2 |
| 2009 | 1 | 1 |
| 2010 | 2 | 2 |
| 2011 | 2 | 5 |
| 2012 | 1 | 1 |
| 2013 | 3 | 4 |
| 2014 | 0 | 5 |
| 2015 | 3 | 6 |
| 2016 | 4 | 4 |
| 2017 | 3 | 4 |
| 2018 | 2 | 6 |
| 2019 | 2 | 5 |
| 2020 | 3 | 3 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 4 |
| 2024 | 1 | 3 |
| 2025 | 0 | 1 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Magnetic point-of-care systems and assays for determining GFAP in biological samples30 Jun 2026US 12,669,513 B2Abbott Laboratories
- Protein biomarker and uses thereof24 Mar 2026US 12,583,938 B2Amgen Inc.
- Protein biomarker and uses thereof16 Jan 2024US 11,873,344 B2Amgen Inc.
- Methods for cardiomyocyte survival, proliferation or differentiation by NRG-221 Jul 2020US 10,717,775 B2Acorda Therapeutics, Inc.
- Method for achieving desired glial growth factor 2 plasma levels9 Jun 2020US 10,675,331 B2Acorda Therapeutics, Inc.
- Magnetic point-of-care systems and assays for determining gfap in biological samples8 Oct 2026US 2026/0309722 A1Abbott Laboratories
- Biomarkers8 Jan 2026US 2026/0009802 A1Oxford University Innovation Limited
- Method for assessing differentiation potential of cells in culture broth in differentiation of pluripotent stem cells into neural cells of midbrain floor plate region8 May 2025US 2025/0145948 A1Kyoto University
- Composition and kit for diagnosing cancer and method for diagnosing cancer using same13 Jun 2024US 2024/0192218 A1
- Protein biomarker and uses thereof14 Mar 2024US 2024/0084037 A1Amgen Inc.
Most cited
By later US patents
- Cardiac muscle function and manipulation55US 7,226,907 B1Zensun (Shanghai) Science & Technology, Co., Ltd. · 2007
- Antibodies to HER4, human receptor tyrosine kinase51US 5,811,098 ABristol-Myers Squibb Company · 1998
- Cardiac muscle function and manipulation42US 7,612,164 B2Zensun (Shanghai) Science and Technologies Ltd. · 2009
- Cardiac muscle function and manipulation35US 7,964,555 B2Zensun (Shanghai) Sci. & Tech. Ltd. · 2011
- Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-235US 8,114,838 B2Acorda Therapeutics, Inc. · 2012